Xeris Biopharma Holdings

PriceXeris Biopharma Holdings

XERS

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing’s syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Historical stock price chart and annual return over the past years

38%

5 years

% Total

XERS
7%

5 years

Annual Return

XERS